# Mirum Pharmaceuticals, Inc.: Form 8-K, filed Jan 16, 2024

- Company: [Mirum Pharmaceuticals, Inc.](/companies/mirm.md) (CIK 1759425)
- Form: 8-K
- Filed: 2024-01-16
- Accepted by EDGAR: Jan 16, 2024, 16:15 ET
- Period: 2024-01-11
- Accession: 0001193125-24-008569
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1759425/000119312524008569/d723597d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1759425/000119312524008569/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1759425/000119312524008569/d723597d8k.htm

Filed Jan 16, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-008569. Last ingested by Listed: Nov 10, 2026, 16:59 ET. No prices; not investment advice.
